BlackRock Health Sciences Term Trust (NYSE:BMEZ) Declares $0.18 Monthly Dividend

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Friday, November 1st,NASDAQ Dividends reports. Shareholders of record on Friday, November 15th will be given a dividend of 0.1769 per share on Friday, November 29th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 13.53%. The ex-dividend date of this dividend is Friday, November 15th.

BlackRock Health Sciences Term Trust has raised its dividend by an average of 20.7% annually over the last three years.

BlackRock Health Sciences Term Trust Stock Down 0.9 %

Shares of BMEZ stock traded down 0.15 during trading hours on Wednesday, reaching 15.69. 215,358 shares of the company traded hands, compared to its average volume of 264,385. BlackRock Health Sciences Term Trust has a 12-month low of 13.41 and a 12-month high of 16.59. The firm has a 50-day moving average price of 15.80 and a 200 day moving average price of 15.56.

Insider Transactions at BlackRock Health Sciences Term Trust

In related news, major shareholder Saba Capital Management, L.P. bought 1,633 shares of the business’s stock in a transaction dated Friday, September 27th. The shares were purchased at an average price of 15.89 per share, with a total value of 25,948.37. Following the transaction, the insider now owns 20,653,378 shares in the company, valued at 328,182,176.42. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have bought 99,630 shares of company stock valued at $1,585,113 in the last ninety days.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.